Literature DB >> 27143415

A case of anomalous left coronary artery obstruction caused by lotus valve implantation.

Isamu Mizote1, Lenard Conradi2, Ulrich Schäfer1.   

Abstract

Trans-catheter aortic valve implantation (TAVI) in patients with high surgical risk is an alternative therapeutic option for severe aortic stenosis. Although second generation TAVI devices are available now, this therapy still cannot overcome all serious complications. Among them, coronary obstruction is a life threatening complication, however, there is no report concerning the complication in patients with anomalous coronary arteries. Here we present a case with coronary obstruction of an anomalous left main coronary that occurred after implantation of the mechanical expanding Lotus valve (Boston Scientific Inc.).
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  trans-catheter aortic valve implantation (TAVI); coronary obstruction; anomalous coronary artery of the opposite sinus (ACAOS)

Mesh:

Year:  2016        PMID: 27143415     DOI: 10.1002/ccd.26541

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Modeling risk of coronary obstruction during transcatheter aortic valve replacement.

Authors:  Megan Heitkemper; Hoda Hatoum; Amirsepehr Azimian; Breandan Yeats; Jennifer Dollery; Bryan Whitson; Greg Rushing; Juan Crestanello; Scott M Lilly; Lakshmi Prasad Dasi
Journal:  J Thorac Cardiovasc Surg       Date:  2019-05-18       Impact factor: 5.209

2.  Coronary Artery Occlusion during Transcatheter Aortic Valve Implantation: Early Recognition Have Better Outcome.

Authors:  Mohamed Abdunasser M Baghi; Khaled Taufek Othman; Abdu Rahman H Alnabti; Salem M Abujalala
Journal:  Heart Views       Date:  2022-05-16

3.  Simple 2-dimensional anatomic model to predict the risk of coronary obstruction during transcatheter aortic valve replacement.

Authors:  Megan Heitkemper; Srikrishna Sivakumar; Hoda Hatoum; Jennifer Dollery; Scott M Lilly; Lakshmi Prasad Dasi
Journal:  J Thorac Cardiovasc Surg       Date:  2020-02-19       Impact factor: 6.439

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.